Search results
Controversy erupts as Kansas AG Kobach slams Pfizer's 'misleading' vaccine marketing
The Raw Story· 2 days agoTOPEKA — Attorney General Kris Kobach filed a civil lawsuit Monday against pharmaceutical company ...
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 2 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Merck Prepares to Take on Pfizer After Pneumococcal Vaccine Approval
Barrons.com· 1 day agoPfizer currently dominates the market for pneumococcal vaccines, which protect against bacterial...
Kansas attorney general sues Pfizer over COVID vaccine, company responds
KSNT Topeka· 2 days agoRelated video: Class action lawsuits – what are they, and should you join one? TOPEKA (KSNT) –...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 6 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
MSD competes with Pfizer in pneumococcal vaccine market after FDA approval
Pharmaceutical Technology via Yahoo Finance· 1 day agoMSD’s 21-valent pneumococcal vaccine introduces a new rival to Pfizer’s 20-valent product Prevnar 20...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Merck's vaccine approval poses threat to one of Pfizer's top-selling products
Morningstar· 2 days agoMerck & Co. Inc. on Monday gained U.S. regulatory approval for a vaccine that could become a tough competitor to one of Pfizer Inc.'s top-selling products ...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 2 days agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
BioPharma Dive via Yahoo Finance· 2 days agoThe advisory committee is set to meet on June 27. Merck set the price of Capvaxive at $287 per...In...